Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at alternating eribulin and hormone therapy for advanced breast cancer

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for women whose disease has spread into surrounding tissue or to another part of the body. They should also have oestrogen receptor positive breast cancer.

Recruitment start: 28 October 2015

Recruitment end: 28 February 2018

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Laura Kenny

Supported by

Action Against Cancer

Eisai

Experimental Cancer Medicine Centre (ECMC)

Imperial College of Science Technology and Medicine

Last reviewed: 28 Feb 2018

CRUK internal database number: 14050

Help and support